anlak storytelling
All kinds
Document kinds
Loading document kinds...

Primary corpus lens for browsing and insights. Selection lives in the URL.

All formats
Orientation
Loading formats...

Landscape, portrait, square, or unknown document geometry.

Unlock
slides · global inventory

All filtered slides

Global slide inventory for the active corpus filters, with each row opening the slide detail view.

Search Insights JSON Unlock
Corpus coverage

319,975 slides

319,974 are described (100%), so the treemap can explain the corpus instead of just counting files.

Total slides
319,975
Described
319,974
Pending
1

Slide type composition

dynamicclickable
Slide type

Showing 319,974 described slides — 100.0% of 319,975 rendered pages

+Context & problem43,76713.7% · 6,592 docs+Data & charts72,62022.7% · 8,666 docs+Meta & navigation45,93614.4% · 9,739 docs+Recommend & act67,04121.0% · 9,324 docs+Cases & evidence31,2569.8% · 6,067 docs+Frameworks2,1230.7% · 1,232 docs+Appendix35,68211.2% · 6,614 docs+Other21,5496.7% · 5,566 docs

Tile area is proportional to slide count. Click a category to open its subtype map.

all document kinds · all orientations
18 30 60

Slide collection

212,521-212,580 of 319,975

filter-aware
16
The slide presents two distinct tables: one for cash flow (left) and one for net debt (right).Embracer Group | Results Presentation Deck | 25 slides · Embracer Group
Conference presentation Investor relations Beat · Financials1 hit
17
The forecast range is SEK 7,000 – 9,000 million.Embracer Group | Results Presentation Deck | 25 slides · Embracer Group
Conference presentation Investor relations 1 hit
18
The background image is highly stylized and dark, contrasting with the simple, bold white text.Embracer Group | Results Presentation Deck | 25 slides · Embracer Group
Conference presentation Investor relations Loop · Cost Of Inaction1 hit
19
Embracer Group | Results Presentation Deck | 25 slidesEmbracer Group | Results Presentation Deck | 25 slides · Embracer Group
Conference presentation Investor relations Loop · Cost Of Inaction1 hit
20
The slide outlines specific financial targets for the Embracer Group restructuring program.Embracer Group | Results Presentation Deck | 25 slides · Embracer Group
Conference presentation Investor relations Beat · SolutionLoop · Cost Of Inaction1 hit
21
The slide uses a horizontal bar chart style to represent a phased timeline.Embracer Group | Results Presentation Deck | 25 slides · Embracer Group
Conference presentation Investor relations Beat · SolutionLoop · Cost Of Inaction1 hit
22
Part of a Q1 update presentation for Embracer Group.Embracer Group | Results Presentation Deck | 25 slides · Embracer Group
Conference presentation Investor relations Beat · SolutionLoop · Cost Of Inaction1 hit
23
The background features a stylized 'A' shape composed of various photos of employees/work environments.Embracer Group | Results Presentation Deck | 25 slides · Embracer Group
Conference presentation Investor relations 1 hit
24
Embracer Group | Results Presentation Deck | 25 slidesEmbracer Group | Results Presentation Deck | 25 slides · Embracer Group
Conference presentation Investor relations 1 hit
25
Embracer Group | Results Presentation Deck | 25 slidesEmbracer Group | Results Presentation Deck | 25 slides · Embracer Group
Conference presentation Investor relations 1 hit
01
Slide 1
Enochian Biosciences | Results Presentation Deck | 43 slidesEnochian Biosciences | Results Presentation Deck | 43 slides · Renovaro Biosciences
Pitch deck Investor relations 1 hit
02
Enochian Biosciences | Results Presentation Deck | 43 slidesEnochian Biosciences | Results Presentation Deck | 43 slides · Renovaro Biosciences
Pitch deck Investor relations 1 hit
03
Enochian Biosciences | Results Presentation Deck | 43 slidesEnochian Biosciences | Results Presentation Deck | 43 slides · Renovaro Biosciences
Pitch deck Investor relations 1 hit
04
Enochian Biosciences | Results Presentation Deck | 43 slidesEnochian Biosciences | Results Presentation Deck | 43 slides · Renovaro Biosciences
Pitch deck Investor relations 1 hit
05
The slide uses a visual metaphor of donor vs patient cells to explain the mechanism of action.Enochian Biosciences | Results Presentation Deck | 43 slides · Renovaro Biosciences
Pitch deck Investor relations 1 hit
06
The slide uses a chevron-based process flow to map disease states to market validation.Enochian Biosciences | Results Presentation Deck | 43 slides · Renovaro Biosciences
Pitch deck Investor relations 1 hit
07
The slide uses a flow-based diagram to show how pipeline assets are developed and then monetized through various business strategies.Enochian Biosciences | Results Presentation Deck | 43 slides · Renovaro Biosciences
Pitch deck Investor relations 1 hit
08
The slide uses a Gantt-style timeline to show progress of various therapeutic programs.Enochian Biosciences | Results Presentation Deck | 43 slides · Renovaro Biosciences
Pitch deck Investor relations 1 hit
09
The slide uses a card-based layout to display five key executives with their titles and previous company affiliations.Enochian Biosciences | Results Presentation Deck | 43 slides · Renovaro Biosciences
Pitch deck Investor relations 1 hit
10
Enochian Biosciences | Results Presentation Deck | 43 slidesEnochian Biosciences | Results Presentation Deck | 43 slides · Renovaro Biosciences
Pitch deck Investor relations 1 hit
11
Enochian Biosciences | Results Presentation Deck | 43 slidesEnochian Biosciences | Results Presentation Deck | 43 slides · Renovaro Biosciences
Pitch deck Investor relations 1 hit
12
Enochian Biosciences | Results Presentation Deck | 43 slidesEnochian Biosciences | Results Presentation Deck | 43 slides · Renovaro Biosciences
Pitch deck Investor relations 1 hit
13
The slide uses a quote from a subject matter expert to build credibility.Enochian Biosciences | Results Presentation Deck | 43 slides · Renovaro Biosciences
Pitch deck Investor relations 1 hit
14
The slide uses a biological process diagram to illustrate the mechanism of immune activation.Enochian Biosciences | Results Presentation Deck | 43 slides · Renovaro Biosciences
Pitch deck Investor relations Beat · ProblemLoop · Cost Of Inaction1 hit
15
The slide uses a visual comparison to illustrate two distinct evasion strategies: starving killer T-cells and recruiting protective T-reg cells.Enochian Biosciences | Results Presentation Deck | 43 slides · Renovaro Biosciences
Pitch deck Investor relations Beat · ProblemLoop · Cost Of Inaction1 hit
16
The diagram uses a callout-style list to map specific cellular functions to a central dendritic cell illustration.Enochian Biosciences | Results Presentation Deck | 43 slides · Renovaro Biosciences
Pitch deck Investor relations Beat · Solution1 hit
17
The slide uses a circular process flow to represent the manufacturing cycle of a personalized cell therapy.Enochian Biosciences | Results Presentation Deck | 43 slides · Renovaro Biosciences
Pitch deck Investor relations Beat · Solution1 hit
18
Includes statistical significance markers (p-values) and sample sizes (n).Enochian Biosciences | Results Presentation Deck | 43 slides · Renovaro Biosciences
Pitch deck Investor relations Loop · Quick Win Big Bet1 hit
19
The slide acts as a pointer to a specific external scientific presentation.Enochian Biosciences | Results Presentation Deck | 43 slides · Renovaro Biosciences
Pitch deck Investor relations Loop · Quick Win Big Bet1 hit
20
The slide uses a ribbon-style process diagram to show progression.Enochian Biosciences | Results Presentation Deck | 43 slides · Renovaro Biosciences
Pitch deck Investor relations Beat · Impact & Next Steps1 hit
21
Enochian Biosciences | Results Presentation Deck | 43 slidesEnochian Biosciences | Results Presentation Deck | 43 slides · Renovaro Biosciences
Pitch deck Investor relations Beat · Impact & Next Steps1 hit
22
Enochian Biosciences | Results Presentation Deck | 43 slidesEnochian Biosciences | Results Presentation Deck | 43 slides · Renovaro Biosciences
Pitch deck Investor relations Beat · Impact & Next Steps1 hit
23
Enochian Biosciences | Results Presentation Deck | 43 slidesEnochian Biosciences | Results Presentation Deck | 43 slides · Renovaro Biosciences
Pitch deck Investor relations Beat · Impact & Next Steps1 hit
24
The slide features the Renovaro Biosciences logo and a stylized botanical/cellular graphic background.Enochian Biosciences | Results Presentation Deck | 43 slides · Renovaro Biosciences
Pitch deck Investor relations Beat · Impact & Next Steps1 hit
25
The slide uses a process flow diagram to explain the therapeutic intervention.Enochian Biosciences | Results Presentation Deck | 43 slides · Renovaro Biosciences
Pitch deck Investor relations Beat · Impact & Next Steps1 hit
26
The slide uses a chevron-style process flow to represent chronological progress.Enochian Biosciences | Results Presentation Deck | 43 slides · Renovaro Biosciences
Pitch deck Investor relations Beat · Impact & Next Steps1 hit
27
Enochian Biosciences | Results Presentation Deck | 43 slidesEnochian Biosciences | Results Presentation Deck | 43 slides · Renovaro Biosciences
Pitch deck Investor relations Beat · Impact & Next Steps1 hit
28
Enochian Biosciences | Results Presentation Deck | 43 slidesEnochian Biosciences | Results Presentation Deck | 43 slides · Renovaro Biosciences
Pitch deck Investor relations Beat · Impact & Next Steps1 hit
29
The chart shows a significant drop in viral load starting around day 14, stabilizing at a low level from day 145 onwards.Enochian Biosciences | Results Presentation Deck | 43 slides · Renovaro Biosciences
Pitch deck Investor relations Beat · Impact & Next Steps1 hit
30
Enochian Biosciences | Results Presentation Deck | 43 slidesEnochian Biosciences | Results Presentation Deck | 43 slides · Renovaro Biosciences
Pitch deck Investor relations Beat · Impact & Next Steps1 hit
31
Enochian Biosciences | Results Presentation Deck | 43 slidesEnochian Biosciences | Results Presentation Deck | 43 slides · Renovaro Biosciences
Pitch deck Investor relations Beat · Impact & Next Steps1 hit
32
Enochian Biosciences | Results Presentation Deck | 43 slidesEnochian Biosciences | Results Presentation Deck | 43 slides · Renovaro Biosciences
Pitch deck Investor relations Beat · Impact & Next Steps1 hit
33
Enochian Biosciences | Results Presentation Deck | 43 slidesEnochian Biosciences | Results Presentation Deck | 43 slides · Renovaro Biosciences
Pitch deck Investor relations Beat · Impact & Next Steps1 hit
34
Enochian Biosciences | Results Presentation Deck | 43 slidesEnochian Biosciences | Results Presentation Deck | 43 slides · Renovaro Biosciences
Pitch deck Investor relations Beat · Impact & Next Steps1 hit
35
The slide uses a comparative diagram to illustrate the selective mechanism of action.Enochian Biosciences | Results Presentation Deck | 43 slides · Renovaro Biosciences
Pitch deck Investor relations Beat · Impact & Next Steps1 hit
36
The slide uses a ribbon-style process diagram to represent sequential or cumulative progress.Enochian Biosciences | Results Presentation Deck | 43 slides · Renovaro Biosciences
Pitch deck Investor relations Beat · Impact & Next Steps1 hit
37
The slide uses a quote from a key advisor to validate the scientific potential of the company's technology beyond its primary cancer focus.Enochian Biosciences | Results Presentation Deck | 43 slides · Renovaro Biosciences
Pitch deck Investor relations Beat · Impact & Next Steps1 hit
38
Enochian Biosciences | Results Presentation Deck | 43 slidesEnochian Biosciences | Results Presentation Deck | 43 slides · Renovaro Biosciences
Pitch deck Investor relations Beat · Impact & Next Steps1 hit
39
Enochian Biosciences | Results Presentation Deck | 43 slidesEnochian Biosciences | Results Presentation Deck | 43 slides · Renovaro Biosciences
Pitch deck Investor relations Beat · Impact & Next Steps1 hit
40
Enochian Biosciences | Results Presentation Deck | 43 slidesEnochian Biosciences | Results Presentation Deck | 43 slides · Renovaro Biosciences
Pitch deck Investor relations Beat · Impact & Next Steps1 hit
41
The slide uses a horizontal arrow-based timeline structure to map specific drug candidates to their upcoming regulatory and clinical milestones.Enochian Biosciences | Results Presentation Deck | 43 slides · Renovaro Biosciences
Pitch deck Investor relations Beat · Impact & Next Steps1 hit
42
Enochian Biosciences | Results Presentation Deck | 43 slidesEnochian Biosciences | Results Presentation Deck | 43 slides · Renovaro Biosciences
Pitch deck Investor relations 1 hit
43
Enochian Biosciences | Results Presentation Deck | 43 slidesEnochian Biosciences | Results Presentation Deck | 43 slides · Renovaro Biosciences
Pitch deck Investor relations 1 hit
01
Slide 1
Eos Energy | Results Presentation Deck | 13 slidesEos Energy | Results Presentation Deck | 13 slides · Eos Energy Enterprises
Conference presentation Investor relations Beat · Attention1 hit
02
Eos Energy | Results Presentation Deck | 13 slidesEos Energy | Results Presentation Deck | 13 slides · Eos Energy Enterprises
Conference presentation Investor relations Beat · Attention1 hit
03
The slide uses a background image of an Eos energy storage container.Eos Energy | Results Presentation Deck | 13 slides · Eos Energy Enterprises
Conference presentation Investor relations Beat · Attention1 hit
04
Eos Energy | Results Presentation Deck | 13 slidesEos Energy | Results Presentation Deck | 13 slides · Eos Energy Enterprises
Conference presentation Investor relations Beat · Need1 hit
05
The slide uses a three-pillar structure to explain the transition from Gen 2.3 to Z3.Eos Energy | Results Presentation Deck | 13 slides · Eos Energy Enterprises
Conference presentation Investor relations Beat · NeedLoop · Cost Of Inaction1 hit
06
The slide uses a three-column layout to categorize manufacturing progress into production status, system assembly, and future design.Eos Energy | Results Presentation Deck | 13 slides · Eos Energy Enterprises
Conference presentation Investor relations Beat · SatisfactionLoop · Cost Of Inaction1 hit
07
The slide uses a dual-axis-like conceptual chart to show price vs cost convergence, with a callout for IRA impact.Eos Energy | Results Presentation Deck | 13 slides · Eos Energy Enterprises
Conference presentation Investor relations Beat · SatisfactionLoop · Cost Of Inaction1 hit